2010
DOI: 10.1016/j.humimm.2010.01.017
|View full text |Cite
|
Sign up to set email alerts
|

Synergistic effect and VEGF/HSP70-hom haplotype analysis: Relationship to prostate cancer risk and clinical outcome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2010
2010
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 10 publications
(4 citation statements)
references
References 56 publications
0
4
0
Order By: Relevance
“…As for the HSP70-2 and HSP70-hom polymorphisms, the HSP70-2 A+1267G polymorphism is a synonymous mutation located at the coding region and is likely to affect the secondary structure of mRNA, thus affecting the stability of mRNA and protein expression, and the HSP70-hom T > C polymorphism has nonsynonymous mutations, which leads to a Met to Thr substitution at position 493 in the peptide binding domain and may affect substrate binding specificity and chaperone activity of HSP70 [6]. Some investigations demonstrated that genetic alteration of the HSP70-2 and/or HSP70-hom can modulate cancer susceptibility and that the frequency of the variant genotype was significantly higher in patients when compared with controls [11, 12, 18, 22]. However, the association of Ala variants and cancer risk was not validated by others [16, 21, 25, 27, 28].…”
Section: Discussionmentioning
confidence: 99%
“…As for the HSP70-2 and HSP70-hom polymorphisms, the HSP70-2 A+1267G polymorphism is a synonymous mutation located at the coding region and is likely to affect the secondary structure of mRNA, thus affecting the stability of mRNA and protein expression, and the HSP70-hom T > C polymorphism has nonsynonymous mutations, which leads to a Met to Thr substitution at position 493 in the peptide binding domain and may affect substrate binding specificity and chaperone activity of HSP70 [6]. Some investigations demonstrated that genetic alteration of the HSP70-2 and/or HSP70-hom can modulate cancer susceptibility and that the frequency of the variant genotype was significantly higher in patients when compared with controls [11, 12, 18, 22]. However, the association of Ala variants and cancer risk was not validated by others [16, 21, 25, 27, 28].…”
Section: Discussionmentioning
confidence: 99%
“…However, in BRCA1 carriers the low-VEGF T-allele confers protection from disease (Jakubowska et al 2008). Similarly, although large case-control studies have failed to find an association between prostate cancer risk and VEGF polymorphisms (Jacobs et al 2008), when gene-gene interactions are considered, several smaller studies have shown that VEGF polymorphisms can play a role in disease risk or aggressiveness (Sfar et al 2010; VanCleave et al 2010).…”
Section: Common Polymorphisms In Angiogenesismentioning
confidence: 99%
“…3 Recent studies suggest that genetic polymorphisms of genes involved in prostate angiogenesis may confer susceptibility to PCa. [4][5][6] Angiogenesis is essential for tumor development and metastasis, and in various types of tumors, including urological malignancies, it has been reported that angiogenesis was closely associated with advanced disease status and poor prognosis. 7,8 The hypoxia-inducible factor-1 (HIF-1) plays an important role in regulating angiogenesis, cell adhesion, metastatic spread and apoptosis.…”
Section: Introductionmentioning
confidence: 99%